(0.09%) 5 104.45 points
(0.24%) 38 332 points
(0.12%) 15 947 points
(-1.32%) $82.74
(6.50%) $2.05
(-0.05%) $2 346.10
(-0.24%) $27.47
(3.90%) $958.10
(-0.20%) $0.933
(-0.31%) $10.99
(-0.51%) $0.796
(1.67%) $93.41
Live Chart Being Loaded With Signals
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally...
Stats | |
---|---|
今日成交量 | 216 849 |
平均成交量 | 215 038 |
市值 | 51.23M |
EPS | £0 ( 2024-04-11 ) |
Last Dividend | £0.0400 ( 2018-05-24 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.50 |
ATR14 | £0.452 (1.11%) |
Venture Life Group PLC 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Venture Life Group PLC 财务报表
Annual | 2023 |
营收: | £51.41M |
毛利润: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2023 |
营收: | £51.41M |
毛利润: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2022 |
营收: | £43.98M |
毛利润: | £17.67M (40.17 %) |
EPS: | £0.00410 |
FY | 2021 |
营收: | £32.76M |
毛利润: | £12.96M (39.55 %) |
EPS: | £0.0278 |
Financial Reports:
No articles found.
Venture Life Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0400 | 2014-06-11 |
Last Dividend | £0.0400 | 2018-05-24 |
Next Dividend | £0 | N/A |
Payout Date | 2018-06-22 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £0.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 8.11 | |
Div.Growth Potential Score | 4.20 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0.0400 | 0.10% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TPT.L | Dividend Knight | 2023-06-08 | Annually | 27 | 2.93% | |
MATE.L | Dividend Knight | 2023-06-29 | Quarterly | 7 | 2.31% | |
CRN.L | Dividend King | 2023-09-14 | Annually | 6 | 3.87% | |
RWS.L | Dividend Knight | 2023-06-22 | Semi-Annually | 21 | 1.50% | |
HMSO.L | Dividend Junior | 2023-08-24 | Annually | 32 | 1.96% | |
BBGI.L | Dividend Knight | 2023-09-07 | Semi-Annually | 13 | 2.94% | |
VSL.L | Dividend Knight | 2023-09-07 | Quarterly | 10 | 5.70% | |
MTVW.L | Dividend Knight | 2023-07-06 | Semi-Annually | 32 | 2.55% | |
DSCV.L | Dividend Knight | 2023-06-22 | Annually | 33 | 0.73% | |
SMDS.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 2.56% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0179 | 1.500 | 9.64 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00771 | 1.200 | 9.74 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0123 | 1.500 | -0.975 | -1.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.084 | 0.800 | 9.58 | 7.67 | [1 - 3] |
quickRatioTTM | 0.735 | 0.800 | -0.380 | -0.304 | [0.8 - 2.5] |
cashRatioTTM | 0.189 | 1.500 | -0.0587 | -0.0880 | [0.2 - 2] |
debtRatioTTM | 0.204 | -1.500 | 6.60 | -9.90 | [0 - 0.6] |
interestCoverageTTM | 3.00 | 1.000 | -0.00174 | -0.00174 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.320 | -1.500 | 8.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.95 | 8.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0865 | 1.000 | -0.271 | -0.271 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.430 | 0.800 | -0.465 | -0.372 | [0.5 - 2] |
Total Score | 8.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.00 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0123 | 2.50 | -0.627 | -1.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 77.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 4.20 |
Venture Life Group PLC
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。